Simple blood test may predict infection after kidney stone surgery

NCT ID NCT04669886

Recruiting now Knowledge-focused Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether a blood test that measures endotoxin levels can predict the risk of infection after a type of kidney stone surgery called percutaneous nephrolithotomy (PCNL). Researchers will enroll 150 adults scheduled for this surgery and measure their endotoxin levels before and after the procedure. The goal is to see if higher levels are linked to complications like fever or systemic inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test that helps doctors identify patients at high risk for infection after kidney stone surgery, allowing for earlier treatment.
What could go wrong: This is an early observational study, not a treatment trial. The blood test may not accurately predict infections, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROLITHIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fever nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEPHROLITHIASIS UROSEPSIS

Contacts and locations

Locations

University of Miami
RECRUITING

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.